ESR1 and neoplasm: Most breast cancers express estrogen receptors (ERs), which indicate better prognosis and predict responsiveness to hormone therapy.1, 2, 3Conventional immunohistochemical methods of determining ER status of breast cancers are limited by sampling error and tumor heterogeneity.4